To use Oracle BIEE, please enable javascript in your browser.
The number of individual cases identified in EudraVigilance for COVID-19 VACCINE JANSSEN (AD26.COV2.S) is 21,143 (up to 07/08/2021)

Number of individual cases by Age Group

 
 
 
 
Age Group
Cases
%
Not Specified 2,005 9.5%
0-1 Month 1 0.0%
2 Months - 2 Years 5 0.0%
3-11 Years 2 0.0%
12-17 Years 18 0.1%
18-64 Years 17,681 83.6%
65-85 Years 1,289 6.1%
More than 85 Years 142 0.7%
Total 21,143 100.0%

Number of individual cases by Sex

 
 
 
 
Sex
Cases
%
Female 12,984 61.4%
Male 7,881 37.3%
Not Specified 278 1.3%
Total 21,143 100.0%

Number of individual cases by Geographic Origin (EEA/Non-EEA)

 
 
 
 
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area 16,692 78.9%
Non European Economic Area 4,451 21.1%
Not Specified 0  
Total 21,143 100.0%

Number of individual cases by Reporter Group

 
 
 
 
Reporter Group
Cases
%
Healthcare Professional 5,076 24.0%
Non Healthcare Professional 16,067 76.0%
Not Specified 0  
Total 21,143 100.0%
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu